nalfurafine
SMILES | CN([C@@H]1CC[C@@]2([C@@]34[C@H]1Oc1c4c(C[C@H]2N(CC3)CC2CC2)ccc1O)O)C(=O)/C=C/c1ccoc1 |
InChIKey | XGZZHZMWIXFATA-UEZBDDGYSA-N |
Chemical properties
Hydrogen bond acceptors | 6 |
Hydrogen bond donors | 2 |
Rotatable bonds | 5 |
Molecular weight (Da) | 476.2 |
Drug properties
Molecular type | Small molecule |
Physiological/Surrogate | Surrogate |
Approved drug | Yes |
Database connections
Structure pdb | 7YIT |
Bioactivities
Receptor | Activity | Source | |||||||
---|---|---|---|---|---|---|---|---|---|
GTP | Uniprot | Species | Family | Class | Type | Min | Avg | Max | Database |
δ | OPRD | Mouse | Opioid | A | pKi | 7.01 | 7.23 | 7.29 | ChEMBL |
κ | OPRK | Guinea pig | Opioid | A | pKi | 9.64 | 9.71 | 9.77 | ChEMBL |
δ | OPRD | Human | Opioid | A | pKi | 6.16 | 6.8 | 7.44 | ChEMBL |
κ | OPRK | Human | Opioid | A | pKi | 6.77 | 9.28 | 10.72 | ChEMBL |
μ | OPRM | Human | Opioid | A | pKi | 8.22 | 8.69 | 9.15 | ChEMBL |
δ | OPRD | Rat | Opioid | A | pKi | 8.03 | 8.03 | 8.03 | Drug Central |
κ | OPRK | Human | Opioid | A | pKi | 8.02 | 8.02 | 8.02 | Drug Central |
κ | OPRK | Human | Opioid | A | pKd | 10.1 | 10.1 | 10.1 | Guide to Pharmacology |
NOP | OPRX | Human | Opioid | A | pKi | 8.17 | 8.17 | 8.17 | Drug Central |
OX1 | OX1R | Human | Orexin | A | pKi | 8.18 | 8.18 | 8.18 | Drug Central |
OX1 | OX1R | Human | Orexin | A | pKi | 6.6 | 6.6 | 6.6 | ChEMBL |
δ | OPRD | Mouse | Opioid | A | pKi | 8.14 | 8.14 | 8.14 | Drug Central |
κ | OPRK | Mouse | Opioid | A | pKi | 8.01 | 8.01 | 8.01 | Drug Central |
κ | OPRK | Mouse | Opioid | A | pKi | 9.75 | 9.75 | 9.75 | ChEMBL |
κ | OPRK | Guinea pig | Opioid | A | pKi | 8.01 | 8.01 | 8.01 | Drug Central |
μ | OPRM | Mouse | Opioid | A | pKi | 8.03 | 8.03 | 8.03 | Drug Central |
μ | OPRM | Mouse | Opioid | A | pKi | 7.29 | 9.0 | 9.37 | ChEMBL |
Receptor | Activity | Source | |||||||
---|---|---|---|---|---|---|---|---|---|
GTP | Uniprot | Species | Family | Class | Type | Min | Avg | Max | Database |
δ | OPRD | Human | Opioid | A | pEC50 | 7.13 | 7.13 | 7.13 | ChEMBL |
κ | OPRK | Human | Opioid | A | pEC50 | 6.96 | 9.58 | 10.6 | ChEMBL |
μ | OPRM | Human | Opioid | A | pEC50 | 8.77 | 8.96 | 9.14 | ChEMBL |
δ | OPRD | Human | Opioid | A | pEC50 | 8.15 | 8.15 | 8.15 | Drug Central |
μ | OPRM | Human | Opioid | A | pEC50 | 8.04 | 8.04 | 8.04 | Drug Central |
κ | OPRK | Mouse | Opioid | A | pIC50 | 9.38 | 9.38 | 9.38 | ChEMBL |
κ | OPRK | Rat | Opioid | A | pEC50 | 8.03 | 8.03 | 8.03 | Drug Central |
κ | OPRK | Rat | Opioid | A | pEC50 | 8.28 | 8.79 | 9.3 | ChEMBL |